Skip to main
HOLX

Hologic (HOLX) Stock Forecast & Price Target

Hologic (HOLX) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 18%
Buy 18%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Hologic is positioned for a strong financial outlook, primarily driven by anticipated organic revenue growth of 5-7% due to robust procedure volume growth, new product launches, and strategic acquisitions in its Diagnostics and Breast Health segments. The company’s bull case scenario suggests further revenue acceleration into the high-single digits (7-9%), supported by improved operating margins and a strong balance sheet with limited leverage. Additionally, Hologic's emphasis on margin expansion and operational efficiencies indicates a projection of 8-12% earnings growth, highlighting the firm's overall positive trajectory in its core healthcare markets.

Bears say

The financial outlook for Hologic is adversely impacted by anticipated revenue growth slowing to the low-single digits (1-4%), primarily due to weakness in its Diagnostics and Breast Health segments. Despite recent mergers and acquisitions aimed at expanding its asset base, the company has struggled to re-accelerate its top-line growth post-COVID, compounded by risks such as a weak global economy and increased competition in key markets. Consequently, Hologic's operating margins are expected to remain capped in the low-30s, limiting the potential for significant earnings per share growth.

Hologic (HOLX) has been analyzed by 11 analysts, with a consensus rating of Hold. 18% of analysts recommend a Strong Buy, 18% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hologic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hologic (HOLX) Forecast

Analysts have given Hologic (HOLX) a Hold based on their latest research and market trends.

According to 11 analysts, Hologic (HOLX) has a Hold consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hologic (HOLX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.